{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:19:25Z","timestamp":1784697565639,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s40265-016-0571-6","type":"journal-article","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T08:07:06Z","timestamp":1460362026000},"page":"719-729","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Sublingual Sufentanil: A Review in Acute Postoperative Pain"],"prefix":"10.1007","volume":"76","author":[{"given":"James E.","family":"Frampton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,11]]},"reference":[{"issue":"1","key":"571_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bpa.2013.12.001","volume":"28","author":"PP Palmer","year":"2014","unstructured":"Palmer PP, Royal MA, Miller RD. Novel delivery systems for postoperative analgesia. Best Pract Res Clin Anaesthesiol. 2014;28(1):81\u201390.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"4","key":"571_CR2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2217\/pmt.15.22","volume":"5","author":"HS Minkowitz","year":"2015","unstructured":"Minkowitz HS. A review of sufentanil and the sufentanil sublingual tablet system for acute moderate to severe pain. Pain Manag. 2015;5(4):237\u201350.","journal-title":"Pain Manag."},{"issue":"5","key":"571_CR3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1517\/17425247.2015.975202","volume":"12","author":"HS Minkowitz","year":"2015","unstructured":"Minkowitz HS, Candiotti K. The role of sublingual sufentanil nanotabs for pain relief. Expert Opin Drug Deliv. 2015;12(5):845\u201351.","journal-title":"Expert Opin Drug Deliv"},{"key":"571_CR4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0952-8180(93)90013-5","volume":"5","author":"JC Ballantyne","year":"1993","unstructured":"Ballantyne JC, Carr DB, Chalmers TC, et al. Postoperative patient-controlled analgesia: meta-analyses of initial randomized controlled trials. J Clin Anesth. 1993;5:182\u201393.","journal-title":"J Clin Anesth"},{"key":"571_CR5","first-page":"CD003348","volume":"4","author":"J Hudcova","year":"2006","unstructured":"Hudcova J, McNichol E, Quah C, et al. Patient-controlled opioid analgesia versus conventional opioid analgesia for postoperative pain. Cochrane Database Syst Rev. 2006;4:CD003348.","journal-title":"Cochrane Database Syst Rev."},{"key":"571_CR6","first-page":"311","volume":"6","author":"P Palmer","year":"2014","unstructured":"Palmer P, Ji X, Stephens J. Cost of opioid intravenous patient-controlled analgesia: results from a hospital database analysis and literature assessment. Clinicoecon Outcomes Res. 2014;6:311\u20138.","journal-title":"Clinicoecon Outcomes Res."},{"key":"571_CR7","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1213\/01.ane.0000281442.36582.81","volume":"105","author":"SJ Panchal","year":"2007","unstructured":"Panchal SJ, Damaraju CV, Nelson WW, et al. System-related events and analgesic gaps during postoperative pain management with the fentanyl iontophoretic transdermal system and morphine intravenous patient-controlled analgesia. Anesth Analg. 2007;105:1437\u201341.","journal-title":"Anesth Analg"},{"issue":"2","key":"571_CR8","first-page":"146","volume":"33","author":"ER Viscusi","year":"2008","unstructured":"Viscusi ER. Patient-controlled drug delivery for acute postoperative pain management: a review of current and emerging technologies. Reg Anesth Pain Med. 2008;33(2):146\u201358.","journal-title":"Reg Anesth Pain Med"},{"key":"571_CR9","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1213\/01.ANE.0000177102.11682.20","volume":"101","author":"JA Grass","year":"2005","unstructured":"Grass JA. Patient-controlled analgesia. Anesth Analg. 2005;101:S44\u201361.","journal-title":"Anesth Analg"},{"key":"571_CR10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/AJP.0b013e31821d8ac1","volume":"27","author":"HS Smith","year":"2011","unstructured":"Smith HS. The metabolism of opioid agents and the clinical impact of their active metabolites. Clin J Pain. 2011;27:824\u201338.","journal-title":"Clin J Pain"},{"issue":"7","key":"571_CR11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","volume":"84","author":"HS Smith","year":"2009","unstructured":"Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84(7):613\u201324.","journal-title":"Mayo Clin Proc"},{"key":"571_CR12","unstructured":"AcelRx Pharmaceuticals Inc. Zalviso\u2122. http:\/\/www.acelrx.com\/pipeline\/arx-01.html . Accessed 27 Jan 2016."},{"issue":"2","key":"571_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/AAP.0b013e3182791157","volume":"38","author":"HS Minkowitz","year":"2013","unstructured":"Minkowitz HS, Singla NK, Evashenk MA, et al. Pharmacokinetics of sublingual sufentanil tablets and efficacy and safety in the management of postoperative pain. Reg Anesth Pain Med. 2013;38(2):131\u20139.","journal-title":"Reg Anesth Pain Med"},{"issue":"1","key":"571_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clinthera.2014.11.001","volume":"37","author":"SK Willsie","year":"2015","unstructured":"Willsie SK, Evashenk MA, Hamel LG, et al. Pharmacokinetic properties of single- and repeated-dose sufentanil sublingual tablets in healthy volunteers. Clin Ther. 2015;37(1):145\u201355.","journal-title":"Clin Ther"},{"key":"571_CR15","unstructured":"Gr\u00fcnenthal GmbH. Zalviso 15 micrograms sublingual tablets. EU summary of product characteristics. 2016. http:\/\/www.ema.europa.eu . Accessed 13 Jan 2016."},{"issue":"1","key":"571_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/j.1875-9114.1984.tb03304.x","volume":"4","author":"CE Roscow","year":"1984","unstructured":"Roscow CE. Sufentanil citrate: a new opioid analgesic for use in anaesthesia. Pharmacotherapy. 1984;4(1):11\u20139.","journal-title":"Pharmacotherapy."},{"issue":"2","key":"571_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1517\/17425255.2016.1134487","volume":"12","author":"R Babazade","year":"2015","unstructured":"Babazade R, Turan A. Pharmacokinetic and pharmacodynamic evaluation of sublingual sufentanil in the treatment of post-operative pain. Expert Opin Drug Metab Toxicol. 2015;12(2):217\u201324.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"Suppl. 5","key":"571_CR18","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.jpainsymman.2005.01.012","volume":"29","author":"J Lotsch","year":"2005","unstructured":"Lotsch J. Pharmacokinetic-pharmacodynamic modeling of opioids. J Symptom Pain Manage. 2005;29(Suppl. 5):S90\u2013103.","journal-title":"J Symptom Pain Manage."},{"key":"571_CR19","first-page":"209","volume-title":"Geriatric anaesthesiology","author":"SL Shafer","year":"2007","unstructured":"Shafer SL, Flood PD. The pharmacology of opioids in geriatric patients. In: Silverstein JH, Rooke GE, Reves JG, et al., editors. Geriatric anaesthesiology. New York: Springer Science; 2007. p. 209."},{"issue":"1","key":"571_CR20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00000542-199101000-00007","volume":"74","author":"JC Scott","year":"1991","unstructured":"Scott JC, Cooke JE, Stanski DR. Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. Anaesthesiology. 1991;74(1):34\u201342.","journal-title":"Anaesthesiology."},{"key":"571_CR21","unstructured":"Palmer PP. Pharmacokinetics and dose proportionality of sublingual sufentanil NanoTab\u2122 in healthy volunteers. http:\/\/www.acelrx.com . Accessed 21 Jan 2016."},{"key":"571_CR22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1440-1681.1995.tb01945.x","volume":"22","author":"LE Mather","year":"1995","unstructured":"Mather LE. Opioids: a pharmacologist\u2019s delight! Clin Exp Pharmacol Physiol. 1995;22:833\u20136.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"571_CR23","unstructured":"European Medicines Agency. Zalviso: EPAR\u2014public assessment report. 2015. http:\/\/www.ema.europa.eu . Accessed 23 Dec 2015."},{"key":"571_CR24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1460-9592.2010.03411.x","volume":"21","author":"S Lundeberg","year":"2011","unstructured":"Lundeberg S, Roelofse JA. Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice. Paediatr Anaesth. 2011;21:274\u20139.","journal-title":"Paediatr Anaesth"},{"key":"571_CR25","unstructured":"US National Institutes of Health. ClinicalTrials.gov identifier NCT00718081. 2014. https:\/\/clinicaltrials.gov . Accessed 29 Dec 2015."},{"key":"571_CR26","unstructured":"US National Institutes of Health. ClinicalTrials.gov identifier NCT00612534. 2014. https:\/\/clinicaltrials.gov . Accessed 29 Dec 2015."},{"issue":"1","key":"571_CR27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/AAP.0000000000000152","volume":"40","author":"FG Ringold","year":"2015","unstructured":"Ringold FG, Minkowitz HS, Gan TJ, et al. Sufentanil sublingual tablet system for the management of postoperative pain following open abdominal surgery: a randomized, placebo-controlled study. Reg Anesth Pain Med. 2015;40(1):22\u201330.","journal-title":"Reg Anesth Pain Med"},{"issue":"2","key":"571_CR28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/ALN.0000000000000746","volume":"123","author":"M Jove","year":"2015","unstructured":"Jove M, Griffin DW, Minkowitz HS, et al. Sufentanil sublingual tablet system for the management of postoperative pain after knee or hip arthroplasty: a randomized, placebo-controlled study. Anesthesiology. 2015;123(2):434\u201343.","journal-title":"Anesthesiology"},{"issue":"8","key":"571_CR29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/papr.12238","volume":"14","author":"TI Melson","year":"2014","unstructured":"Melson TI, Boyer DL, Minkowitz HS, et al. Sufentanil sublingual tablet system vs. intravenous patient-controlled analgesia with morphine for postoperative pain control: a randomized, active-comparator trial. Pain Pract. 2014;14(8):679\u201388.","journal-title":"Pain Pract."},{"key":"571_CR30","unstructured":"US National Institutes of Health. ClinicalTrials.gov identifier NCT01539538. 2015. https:\/\/clinicaltrials.gov . Accessed 29 Dec 2015."},{"key":"571_CR31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1553-2712.2003.tb01355.x","volume":"10","author":"PE Bijur","year":"2003","unstructured":"Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med. 2003;10:390\u20132.","journal-title":"Acad Emerg Med"},{"key":"571_CR32","unstructured":"Minkowitz H, Ringold F, Jove M, et al. Efficacy and safety of the sufentanil sublingual tablet system (SSTS) in Class 1 and 2 obese patients: the effect of BMI on analgesic response [abstract]. In: The Obesity Society and American Society for Metabolic & Bariatric Surgery Annual Meeting. 2015."},{"key":"571_CR33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-6576.1991.tb03277.x","volume":"35","author":"KA Lehmann","year":"1991","unstructured":"Lehmann KA, Gerhard A, Horrichs-Haermeyer G, et al. Postoperative patient-controlled analgesia with sufentanil: analgesic efficacy and minimum effective concentrations. Acta Anaesthesiol Scand. 1991;35:221\u20136.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"571_CR34","doi-asserted-by":"crossref","first-page":"A117","DOI":"10.1016\/j.jval.2013.03.562","volume":"16","author":"L Schechter","year":"2013","unstructured":"Schechter L, Harshaw Q, Frye CB, et al. Costs associated with intravenous patient controlled analgesia (IV-PCA) in US hospitals [abstract no. PSY39]. Value Health. 2013;16(3):A117.","journal-title":"Value Health."},{"issue":"4","key":"571_CR35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40261-016-0387-x","volume":"36","author":"LJ Scott","year":"2016","unstructured":"Scott LJ. Fentanyl iontophoretic transdermal system: a review in acute postoperative pain. Clin Drug Investig. 2016;36(4):321\u201330.","journal-title":"Clin Drug Investig"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-016-0571-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-016-0571-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-016-0571-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:41:47Z","timestamp":1559504507000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-016-0571-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["571"],"URL":"https:\/\/doi.org\/10.1007\/s40265-016-0571-6","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}